SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q4 2025
Institutional positions in SAB Biotherapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +14 vs. Q3 2025
- Shares held
- 36.3M
- +8.32M (+29.7%) vs. Q3 2025
- Total value
- $135.9M
- +$79.6M (+141.3%) vs. Q3 2025
- New holders
- 21
- 11 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 11,420,000 | $42.7M | 2.76% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,401,500 | $16.5M | 0.17% | 00.0% | Unchanged |
| Commodore Capital LP | 4,401,500 | $16.5M | 1.10% | 00.0% | Unchanged |
| Woodline Partners LP | 2,850,881 | $10.7M | 0.04% | 00.0% | Unchanged |
| Spruce Street Capital LP | 2,198,502 | $8.22M | 2.72% | +2,198,502 | New |
| Sessa Capital IM, L.P. | 2,198,457 | $8.22M | 0.16% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,143,585 | $8.02M | 0.03% | +2,143,585 | New |
| Vanguard Group Inc | 1,847,136 | $6.91M | 0.00% | +1,481,383+405.0% | Added |
| Perceptive Advisors LLC | 803,210 | $3.00M | 0.06% | +803,210 | New |
| Propel Bio Management, LLC | 652,881 | $2.44M | 2.08% | +652,881 | New |
| Jefferies Financial Group Inc. | 580,328 | $2.17M | 0.02% | +580,328 | New |
| Balyasny Asset Management LLC | 475,439 | $1.78M | 0.00% | +475,439 | New |
| Millennium Management LLC | 324,090 | $1.21M | 0.00% | +324,090 | New |
| HB Wealth Management, LLC | 307,500 | $1.15M | 0.01% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 283,645 | $1.06M | 0.00% | +283,645 | New |
| Marshall Wace, LLP | 236,460 | $884.4K | 0.00% | +236,460 | New |
| Simplify Asset Management Inc. | 208,227 | $778.8K | 0.01% | +208,227 | New |
| AWM Investment Company, Inc. | 200,000 | $748.0K | 0.07% | 00.0% | Unchanged |
| StemPoint Capital LP | 146,558 | $548.1K | 0.09% | +146,558 | New |
| Geode Capital Management, LLC | 119,517 | $447.0K | 0.00% | +33,799+39.4% | Added |
| ExodusPoint Capital Management, LP | 86,113 | $322.1K | 0.00% | +86,113 | New |
| Goldman Sachs Group Inc | 51,348 | $192.0K | 0.00% | +40,127+357.6% | Added |
| Pathstone Holdings, LLC | 50,650 | $189.4K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 42,000 | $157.1K | 0.00% | +42,000 | New |
| Qube Research & Technologies Ltd | 31,147 | $116.5K | 0.00% | +31,147 | New |
| Citigroup Inc | 29,974 | $112.1K | 0.00% | +29,142+3,502.6% | Added |
| Verition Fund Management LLC | 26,867 | $100.5K | 0.00% | +26,867 | New |
| ADAR1 Capital Management, LLC | 26,344 | $98.5K | 0.01% | +11,344+75.6% | Added |
| Persistent Asset Partners Ltd | 19,790 | $74.0K | 0.04% | +19,790 | New |
| Colony Group, LLC | 19,201 | $71.8K | 0.00% | +19,201 | New |
| First PREMIER Bank | 18,986 | $71.0K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,650 | $66.0K | 0.00% | +17,650 | New |
| BlackRock, Inc. | 17,239 | $64.5K | 0.00% | +10,900+172.0% | Added |
| Northern Trust Corp | 16,412 | $61.4K | 0.00% | +5,025+44.1% | Added |
| Fifth Lane Capital, LP | 15,000 | $56.1K | 0.07% | +15,000 | New |
| State Street Corp | 13,122 | $49.1K | 0.00% | +13,122 | New |
| Kestra Advisory Services, LLC | 11,550 | $43.2K | 0.00% | −380−3.2% | Reduced |
| Bank of America Corp | 10,613 | $39.7K | 0.00% | +10,539+14,241.9% | Added |
| Caxton Corp | 10,527 | $39.4K | 0.92% | −408−3.7% | Reduced |
| State of Wyoming | 8,971 | $33.6K | 0.00% | +8,971 | New |
| UBS Group AG | 7,398 | $27.7K | 0.00% | −5,823−44.0% | Reduced |
| Advisor Group Holdings, Inc. | 5,024 | $18.8K | 0.00% | +200+4.1% | Added |
| Morgan Stanley | 4,262 | $15.9K | 0.00% | +4,094+2,436.9% | Added |
| JPMorgan Chase & Co | 1,990 | $7.44K | 0.00% | +1,903+2,187.4% | Added |
| MAI Capital Management | 217 | $812 | 0.00% | 00.0% | Unchanged |
| Gs Investments, Inc. | 200 | $748 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 50 | $187 | 0.00% | −2−3.8% | Reduced |
| Harbour Investments, Inc. | 50 | $187 | 0.00% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −932,697−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −566,395−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −80,840−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,982−100.0% | Sold out |
| Kovitz Investment Group Partners, LLC | 0 | $0 | 0.00% | −19,201−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −15,781−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,560−100.0% | Sold out |